Novo’s weight-loss deal highlights its weakness and the seller’s strengths
Hengrui deserves attention because it has not had much of late
Read the full story at Financial TimesOpen in the live monitor
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.